DEF 14C: HeartCore Secures $27M Funding, Plans Reverse Split

HeartCore Enterprises, Inc. announced a $2 million preferred stock sale and a $25 million equity purchase agreement, alongside a planned reverse stock split to maintain Nasdaq listing.

Summary

• HeartCore Enterprises, Inc. (the "Company") has secured approval for two key corporate actions: a significant stock issuance and a reverse stock split.
• The Company entered into a Securities Purchase Agreement (SPA) on June 30, 2025, to issue 2,000 shares of Series A Convertible Preferred Stock to Crom Structured Opportunities Fund I, LP for an aggregate purchase price of $2,000,000. Each preferred share has a stated value of $1,100 and accrues 10% annual dividends.
• Concurrently, an Equity Purchase Agreement (EPA) was signed on June 30, 2025, granting the Company the right to sell up to $25,000,000 in Common Stock to the same investor.
• As part of the SPA, 750,000 shares of Common Stock were issued to the investor for no additional consideration. A commitment fee of $250,000 worth of Common Stock was also paid under the EPA.
• The stock issuances required stockholder approval under Nasdaq Listing Rules 5635(b) and 5635(d) due to the potential for issuing 20% or more of outstanding common stock at a discount and a potential change of control.
• A reverse stock split at a ratio of no less than 1-for-2 and no more than 1-for-30 was also approved, with the exact ratio at the Board's discretion.
• These actions were approved by written consent of the Majority Stockholders (59.55% of voting power) on June 30, 2025, and do not require a further stockholder vote.
• The corporate actions will not be effective until at least 20 days after the mailing of the information statement, which is on or about August 4, 2025.

Sentiment

Score: 5

Explanation: The filing indicates a necessary capital raise and a reverse stock split to address Nasdaq listing compliance, which are typically signs of financial challenges or low stock price. While securing capital is positive for liquidity, the significant potential dilution and the need for a reverse split suggest underlying issues. The sentiment is neutral as these are expected actions for a company in this situation, balancing the positive of securing funds with the negative implications of dilution and a low stock price.

Positives

• Secured up to $25 million in potential equity funding through the Equity Purchase Agreement, providing capital flexibility.
• Raised $2 million through the issuance of Series A Convertible Preferred Stock, enhancing immediate liquidity.
• Obtained stockholder approval for significant stock issuances, removing Nasdaq Listing Rule 5635(b) and 5635(d) restrictions on the number of shares the Company can issue under the agreements.
• Planned reverse stock split aims to increase per-share price, potentially attracting institutional investors and regaining Nasdaq listing compliance.
• The Board retains the authority to abandon the corporate actions, providing flexibility.

Negatives

• The issuance of shares under the Securities Purchase Agreement and Equity Purchase Agreement will have a dilutive effect on existing stockholders' voting power and economic rights.
• The potential issuance of Common Stock could result in a "change of control" for Nasdaq Listing Rule 5635(b) purposes, potentially concentrating share ownership.
• The reverse stock split, while intended to increase share price, carries no assurance that the price will increase proportionally or remain at a level high enough for Nasdaq compliance.
• A reverse stock split may decrease the liquidity of the Common Stock and result in higher transaction costs for stockholders owning "odd lots" (fewer than 100 shares).
• The Series A Convertible Preferred Stock carries a 10% annual dividend, which can be paid in cash or by increasing the stated value (PIK Dividends), potentially increasing future liabilities.
• The Company is restricted from entering into other Equity Line of Credit or Variable Rate Transactions without the Investor's prior written consent while the Equity Purchase Agreement is in effect.

Risks

• Dilution Risk: The issuance of Common Stock upon conversion of Series A Convertible Preferred Stock and under the Equity Purchase Agreement will dilute existing stockholders' voting power and economic rights.
• Change of Control Risk: The potential issuance of Common Stock could lead to a change of control as defined by Nasdaq Listing Rule 5635(b), potentially concentrating ownership and influence.
• Reverse Split Effectiveness Risk: No assurance that the reverse stock split will increase the per-share price proportionally or enable the Company to regain/maintain Nasdaq listing compliance.
• Liquidity and Transaction Cost Risk (Reverse Split): The reverse split may decrease Common Stock liquidity and increase transaction costs for odd lots.
• Market Perception Risk: Other factors like financial results, general market conditions, and market perception could adversely affect the stock price despite the reverse split.
• Operational and Financial Condition Risk: Material adverse effects on the Company's business, operations, properties, or financial condition could impair its ability to perform obligations under the agreements.
• Listing and Trading Suspension Risk: Risk of suspension of trading or delisting of Common Stock by SEC, Nasdaq, or FINRA.
• Registration Statement Effectiveness Risk: Risk that the Registration Statement for resale of shares may not remain effective or available for use.
• Solvency Risk: While the Company states it is not insolvent, there's an inherent risk related to its ability to pay debts as they mature, especially given the need for capital.
• PFIC Status Risk: Risk of being deemed a passive foreign investment company under U.S. tax law if business is not conducted to avoid this.

Future Outlook

The Company aims to use the capital from the equity agreements to support its operations and believes the reverse stock split will enhance its appeal to institutional investors and help it regain compliance with Nasdaq's listing requirements, though there is no guarantee of these outcomes.

Management Comments

• Our Board retains the authority to abandon the Corporate Actions for any reason at any time prior to the effective date(s) of the Corporate Actions.
• The Board has determined that the ability to issue Common Stock pursuant to the SPA, Purchase Agreement and Certificate of Designations are in the best interests of the Company and its stockholders in order to comply with the terms of the SPA, Purchase Agreement and conversion of Series A Convertible Preferred Stock and to receive the benefits of the purchase of the Common Stock pursuant to the terms thereof.
• The Board of Directors primary reasons for approving and recommending the Reverse Split is to make the Common Stock more attractive to certain institutional investors, which would provide for a stronger investor base and to increase the per share price of the Companys Common Stock to regain compliance with the continued listing requirements of the Nasdaq.

Industry Context

The actions reflect a common strategy for smaller publicly traded companies facing low stock prices and capital needs. Reverse stock splits are often used to meet exchange minimum bid price requirements, while equity lines of credit provide flexible access to capital without immediate full dilution. The need for such measures suggests the company may be operating in a challenging market or experiencing growth that outstrips current cash flow.

Comparison to Industry Standards

• The use of a reverse stock split to regain Nasdaq compliance is a common practice among companies whose stock price has fallen below the minimum bid requirement (e.g., $1.00 for Nasdaq). Companies like Sears Holdings (SHLDQ), Rite Aid (RAD), and Bed Bath & Beyond (BBBYQ) have historically used reverse splits to avoid delisting, though success varies.
• Equity lines of credit (ELOCs) or "at-the-market" (ATM) offerings, such as the $25 million Equity Purchase Agreement, are standard financing tools for public companies, particularly those with volatile stock prices or uncertain capital needs. Companies like Sorrento Therapeutics (SRNE) and various biotech firms frequently utilize such agreements to fund operations or clinical trials.
• The 10% dividend on preferred stock is relatively high, indicating a higher cost of capital, which is not uncommon for smaller companies or those perceived as higher risk.
• The 90% of VWAP conversion price for preferred stock and 96% of VWAP for common stock advances are typical discounts offered in such financing arrangements to incentivize investors.

Corporate Governance

Related Party Transactions

• Sumitaka Yamamoto (Chairman, CEO, President, and principal executive officer) and Prakash Sadasivam (Director) are identified as Majority Stockholders who approved the corporate actions by written consent. Their combined ownership is 59.55% of outstanding Common Stock.

Stakeholder Impact

• Shareholders: Existing common stockholders will experience significant dilution from the issuance of new shares. The reverse stock split will reduce the number of shares they own, though their percentage ownership will remain largely the same (except for fractional shares). The goal is to increase per-share price and potentially attract more investors, but there's no guarantee.
• Investors (Crom Structured Opportunities Fund I, LP): This investor gains a significant stake in the company through preferred stock and an equity purchase agreement, with potential for substantial returns if the stock price increases. They also have protective provisions regarding their investment.
• Company (HeartCore Enterprises, Inc.): Gains access to up to $27 million in capital ($2M from preferred, $25M from equity line), which can be used for operations, growth, or to address financial needs. The reverse split aims to improve its Nasdaq listing status.
• Employees/Management: The actions aim to stabilize the company's financial position and market standing, which could provide more stability for employees. Management is directly involved in the decisions and benefits from the company's continued operation and potential growth.

Next Steps

• The Company will publicly announce the effective date of the Reverse Split.
• The Company will file an amendment to its Certificate of Incorporation with the Delaware Secretary of State to effectuate the Reverse Split.
• The Company will file a Current Report on Form 8-K and a Registration Statement with the SEC covering the resale of the issued shares.
• The Company will continue to comply with Nasdaq listing and maintenance requirements.

Key Dates

Recommendation

The filing details a necessary capital raise and a reverse stock split, which are often indicators of a company facing financial or listing challenges. While the capital infusion provides crucial liquidity and the reverse split aims to maintain Nasdaq listing, the significant potential dilution for existing shareholders and the inherent risks associated with reverse splits (e.g., no guarantee of sustained price increase or improved liquidity) warrant caution. An investor should hold to observe if the capital is effectively deployed for growth and if the reverse split successfully stabilizes the stock's market perception and Nasdaq compliance without further adverse effects. Further analysis of the company's underlying business performance and financial health would be required for a stronger recommendation.

Keywords

HeartCore Enterprises, SEC Filing, DEF 14C, Stock Issuance, Convertible Preferred Stock, Equity Purchase Agreement, Reverse Stock Split, Nasdaq Listing Rules, Dilution, Capital Raise, Corporate Governance, HTCR